CharlesStevenGreenbergMD
Hematology • Charleston, SCClotting Disorder, Hemophilia & Bleeding Disorder
Professor
Dr. Greenberg is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
86 Jonathan Lucas St
Charleston, SC 29425Phone+1 843-792-1414
Summary
- Professor of Medicine
Education & Training
Drexel University College of MedicineClass of 1976
Certifications & Licensure
CA State Medical License 1980 - Present
SC State Medical License 2009 - 2025
NC State Medical License 1983 - 2009- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
Awards, Honors, & Recognition
- Elected American Association of Physicians, 2003
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
- Elected Member The American Society for Clinical Investigation, 1988
Clinical Trials
- Evaluation of the Clinical Performance of the Quantra System With the Quantra Surgical Cartridge Start of enrollment: 2017 May 23
- A Phase 3, Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Study of Fostamatinib Disodium in the Treatment of wAIHA Start of enrollment: 2019 Apr 24
Publications & Presentations
PubMed
- 824 citationsTransglutaminases: multifunctional cross-linking enzymes that stabilize tissues.Charles S. Greenberg, Paul J Birckbichler, Robert H. Rice
FASEB Journal. 1991-12-01 - 158 citationsImmediate and reversible platelet inhibition after intravenous administration of a peptide glycoprotein IIb/IIIa inhibitor during percutaneous coronary interventionRobert A. Harrington, Neal S. Kleiman, Kandice Kottke-Marchant, A. Michael Lincoff, James E. Tcheng
The American Journal of Cardiology. 1995-12-15 - 58 citationsFragment D-dimer levels: an objective marker of vaso-occlusive crisis and other complications of sickle cell disease.Dana V. Devine, Thomas R. Kinney, Patricia F. Thomas, Wendell F. Rosse, Charles S. Greenberg
Blood. 1986-07-01
Grant Support
- Tissue Transglutaminase And Vascular RepairNational Heart, Lung, And Blood Institute2003–2006
- Inhibitor Of Angiogenesis And Matrix FormationNational Cancer Institute1996–2002
- Tissue Transglutaminase And Breast Cancer BiologyNational Cancer Institute1997–2001
- Molecular Basis Of VASO Occlusion In Sickle Cell DiseaseNational Heart, Lung, And Blood Institute1996–1997
- Role Of Factor XIII Binding To The Hemostatic PlugNational Heart, Lung, And Blood Institute1989–1993
- Characterization Of Vascular TransglutaminasesNational Heart, Lung, And Blood Institute1985
Professional Memberships
- Member
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
